TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -1 | 4 | 8 | 22 | 30 | 32 | 16 |
| P | %wins | 50 | 100 | 100 | 100 | 100 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/19 19:11 | 6/25/19 | APVO | Aptevo Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Abdun-Nabi Daniel | WA | D | P | 15 | 0.9000 | 0 | 17 | 18 | 109 | D | |||||||||||||||
12/9/13 10:26 | 11/30/13 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | Abdun-Nabi Daniel | MD | DO | CEO | P | 14 | 19.08 | 3 | 1 | 1 | 103 | D | 28 | 47 | 50 | 24 | 16 | 8 | 1 | 2 | -2 | 1 | 8 | 20 | 1 | 14 |
6/4/13 16:21 | 5/31/13 | EBS | Emergent Biosolutions Inc. | DE | Health | Drug | Pharmaceutical Preparations | Abdun-Nabi Daniel | MD | DO | CEO | P | 10 | 12.07 | 2 | 1 | 1 | 96 | D | -43 | -5 | -10 | -8 | -6 | -1 | 0 | 1 | 0 | 7 | 7 | 24 | 58 | 50 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |